期刊文献+

人生长激素对人胰腺癌细胞增殖和凋亡的影响 被引量:2

The effects of human growth hormone on proliferation and apoptosis of human pancreatic carcinoma cells
暂未订购
导出
摘要 目的探讨人生长激素在体内对人胰腺癌细胞增殖和凋亡的影响。方法建立裸鼠胰腺癌移植瘤皮下模型,分为对照组、顺铂(DDP)组、重组人生长激素(rhGH)组和DDP+rhGH组,通过流式细胞仪、免疫组化和TUNEL法检测移植瘤的细胞周期、核增殖抗原、凋亡细胞。结果 DDP组和DDP+rhGH组比对照组或rhGH组S期细胞、核增殖抗原明显降低(P<0.05),凋亡指数明显升高(P<0.05);而rhGH组与对照组各项指标比较无明显差异(P>0.05)。结论外源性人生长激素在体内对人胰腺癌细胞的增殖和凋亡无明显作用。 Objective To study the effects of human growth hormone on proliferation and apoptosis of human pancreatic carcinoma cells of human in vivo. Methods Nude mice were randomly divided into control group,cisplatin (DDP) group,recombinant human growth hormone (rhGH) group and DDP+rhGH group after human gastric cancer xenograft model of nude mice was successfully established. The cell cycle,caryon proliferation antigen (PCNA),apoptosis index (AI)of xenograft were investigated by flow cytometry,immuno-histochemistry,and terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate biotin nick end labeling (TUNEL) respctively. Results Cells in S phase,PCNA of gastric cancer xenograft obviously degraded,but AI obviously increased in DDP group and DDP+rhGH groups compared with control and rhGH groups (P〈0.05). Between rhGH group and control group,there was no difference in above indices. Conclusion Exogenous human growth hormone has no obvious effects on proliferation and apoptosis of human pancreatic cancer cells in vivo.
出处 《成都医学院学报》 CAS 2010年第2期101-104,共4页 Journal of Chengdu Medical College
基金 国家自然科学基金资助项目(30460133) 云南省科技厅资助项目(2007C0012R)
关键词 人生长激素 胰腺癌 细胞周期 核增殖抗原 凋亡 human growth hormone pancreatic cancer cell cycle caryon proliferation antigen apoptosis
  • 相关文献

参考文献4

二级参考文献33

  • 1邱历伟,姚登福,吴信华,吴玮,苏小琴,邹黎.肝癌组织IGF-Ⅱ表达与HBV DNA复制及病理学特征的关系[J].世界华人消化杂志,2006,14(13):1267-1271. 被引量:4
  • 2龚勇,赵秋,杨芳,王渝,马松林.胰腺导管腺癌组织中WT1,IGF-IR表达与细胞凋亡的关系[J].世界华人消化杂志,2006,14(28):2810-2814. 被引量:3
  • 3[1]Inui A.Cancer anorexia-cachexia syndrome:current issues in research and management.CA Cancer J Clin 2002; 52:72-91
  • 4[2]Bowers CY,Momany FA,Reynolds GA,Hong A.On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone.Endocrinology 1984; 114:1537-1545
  • 5[3]Neary NM,Small CJ,Wren AM,Lee JL,Druce MR,Palmieri C,Frost GS,Ghatei MA,Coombes RC,Bloom SR.Ghrelin increases energy intake in cancer patients with impaired appetite:acute,randomized,placebo-controlled trial.J Clin Endocrinol Metab 2004; 89:2832-2836
  • 6[4]Tschop M,Statnick MA,Suter TM,Heiman ML.GHreleasing peptide-2 increases fat mass in mice lacking NPY:indication for a crucial mediating role of hypothalamic agouti-related protein.Endocrinology 2002; 143:558-568
  • 7[5]Laferrere B,Abraham C,Russell CD,Bowers CY.Growth hormone releasing peptide-2 (GHRP-2),like ghrelin,increases food intake in healthy men.J Clin Endocrinol Metab 2005; 90:611-614
  • 8[6]Seeliger H,Guba M,Koehl GE,Doenecke A,Steinbauer M,Bruns CJ,Wagner C,Frank E,Jauch KW,Geissler EK.Blockage of 2-deoxy-D-ribose-induced angiogenesis with rapamycin counteracts a thymidine phosphorylasebased escape mechanism available for colon cancer under 5-fluorouracil therapy.Clin Cancer Res 2004; 10:1843-1852
  • 9Swerdlow AJ, Higgins CD, Adlard P, et al. Risk of cancer in patients treatment with human pituitar growth hormone in the UK.Lancet, 2002,360 : 268-269.
  • 10Giovannucci E, Pollak M. Risk of cancer after growh t-hormone treatment. Lancet,2002,360 : 273-277.

共引文献29

同被引文献10

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部